EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction

Didi Yuan iD, Lian Hu, Yanqing Huang, Haotian Tang, Yuchen Ma, Sai Hu, Junwen Liu

Journal of Cardiovascular Pharmacology and Therapeutics · 2026-04 · 31

DOI: 10.1177/10742484261440344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 16.04.2026. Verfasst von Didi Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Hospital of Changsha, Integrated Traditional Chinese and Western Medicine Hospital of Changsha, Changsha Hospital of Hunan Normal Universi…. Hauptthemen laut MEDLINE: Myocardial Infarction, Mendelian Randomization Analysis, Quantitative Trait Loci, Genome-Wide Association Study. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Natural Science Foundation of Hunan Province, the Project of Top-notch Student Training Bases for Basic Disciplines, the Education Reform Project of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite significant advances in the management of myocardial infarction (MI), therapeutic options targeting upstream pathogenic mechanisms remain scarce. This study introduces a novel multiomics-to-drug discovery framework to identify and validate causal therapeutic targets for MI. We conducted a systematic two-sample Mendelian randomization (MR) analysis integrating expression quantitative trait loci (eQTL) and protein quantitative trait loci (pQTL) data from the IEU OpenGWAS database, with replication in the UK Biobank cohort. Causal inference was rigorously validated using HEIDI heterogeneity tests, Bayesian colocalization, bidirectional MR, and multivariate MR (MVMR) to account for potential confounders. Downstream applications were explored via protein-protein interaction (PPI) network analysis, phenome-wide association studies (PheWAS), and molecular docking simulations. Initial screening identified four candidate genes (BMP1, APOB, FABP2, and ALDH2) associated with MI risk in both discovery and replication cohorts. However, only BMP1 demonstrated consistent causal effects at both transcriptional and proteomic levels, passing all sensitivity analyses with no evidence of horizontal pleiotropy in PheWAS. Colocalization and bidirectional MR further confirmed BMP1 as a robust, independent causal driver of MI. Molecular docking revealed that UK-383367, a selective BMP1 inhibitor, exhibits high binding affinity to the BMP1 active site. While BMP1 is traditionally associated with extracellular matrix remodeling, this study provides the first genetic evidence establishing it as an independent causal risk factor for MI, distinct from conventional traits such as hypertension. By bridging causal genetic inference with structure-based drug prediction, we propose BMP1 inhibition, specifically via agents like UK-383367, as a promising therapeutic strategy to mitigate MI-related pathological remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMendelian Randomization AnalysisQuantitative Trait LociGenome-Wide Association StudyCardiovascular AgentsDrug DiscoveryHumansGenetic Predisposition to DiseaseMolecular Docking SimulationPhenotypeMultiomicsProtein Interaction MapsProteomicsPolymorphism, Single NucleotideUK BiobankRisk FactorsPharmacogenomic VariantsDatabases, Genetic

Stichwörter der Autor:innen

BMP1GWASMendelian randomizationSMRcolocalizationeQTLmultiomicsmyocardial infarctionpQTL

Substanzen

Cardiovascular Agents

Autor:innen und Institutionen

  • The Fourth Hospital of Changsha, Integrated Traditional Chinese and Western Medicine Hospital of Changsha, Changsha Hospital of Hunan Normal University, Yuelu District, Changsha, Hunan, China.
  • Department of Histology and Embryology, Xiangya School of Basic Medical Sciences, Central South University, Yuelu District, Changsha, Hunan, China.

ORCID-Profile: Didi Yuan

Förderung

  • the Natural Science Foundation of Hunan Province
  • the Project of Top-notch Student Training Bases for Basic Disciplines
  • the Education Reform Project of Hunan Province

Zitieren

APA

Yuan, D., Hu, L., Huang, Y., Tang, H., Ma, Y., Hu, S., & Liu, J. (2026). Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction. Journal of Cardiovascular Pharmacology and Therapeutics, 31. https://doi.org/10.1177/10742484261440344

Vancouver

Yuan D, Hu L, Huang Y, Tang H, Ma Y, Hu S, et al. Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction. Journal of Cardiovascular Pharmacology and Therapeutics. 2026;31. doi:10.1177/10742484261440344

BibTeX
@article{Yuan2026,
  author = {Yuan, Didi and Hu, Lian and Huang, Yanqing and Tang, Haotian and Ma, Yuchen and Hu, Sai and Liu, Junwen},
  title = {Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction},
  journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
  year = {2026},
  volume = {31},
  doi = {10.1177/10742484261440344}
}
Kostenlos starten →